News
CQC Case Study: Ampersand’s MyIBD Care – Home Monitoring for Patients with IBD

Posted on 05 Aug 2019
The CQC is the independent regulator of health and social care in England. Their purpose is to make sure people are provided with safe, effective, and high-quality care. They have recently published a series of case studies about driving improvement through technology and MyIBD Care has been selected as a new Telemonitoring technology.

Selected as part of Government’s shortlist to help the most vulnerable & isolated digitally during the Covid19 outbreak
24 Apr 2020

Ampersand – part of Global Digital Health 100
31 Aug 2018

Press Release: Ampersand Health launches a new digital therapeutic for people living with Inflammatory Arthritis
19 Jan 2021
Ampersand Health, experts in digital therapeutics for long-term inflammatory conditions, announce the launch of My Arthritis DTx to support people living with...

Ampersand Health officially announce their partnership with Crohn’s and Colitis UK
17 May 2019

Ampersand to be included in the #Beyond100
21 Jan 2022
We are honoured for Ampersand to be included in the #Beyond100, published by the Department for International Trade (DIT).